Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
G650372-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$620.90
|
|
|
G650372-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$980.90
|
|
| Specifications & Purity | ≥98% |
|---|---|
| Biochemical and Physiological Mechanisms | GGTI-2154 hydrochloride is a potent and selective inhibitor geranylgeranyltransferase I (GGTase I) , with an IC 50 of 21 nM. GGTI-2154 hydrochloride shows more than 200-fold selectivity for GGTase I over FTase (IC50=5600 nM). GGTI-2154 hydrochloride can b |
| Storage Temp | Store at 2-8°C,Desiccated |
| Shipped In |
Wet ice This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
GGTI-2154 hydrochloride is a potent and selective inhibitor geranylgeranyltransferase I (GGTase I) , with an IC 50 of 21 nM. GGTI-2154 hydrochloride shows more than 200-fold selectivity for GGTase I over FTase (IC50=5600 nM). GGTI-2154 hydrochloride can be used for the research of cancer In Vitro GGTI-2154 inhibits the transfer of geranylgeranyl from [ 3 H]GGPP to H-Ras CVLL, with an IC 50 of 21 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo GGTI-2154 (100 mg/kg/day; s.c. for 14 days) induces breast tumor regression in MMTV-ν-Ha-Ras transgenic mice. GGTI-2154 (50 mg/kg/day; i.p. for 50 day) inhibits A-549 tumor growth in nude mice by 60% . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: MMTV-v-Ha-ras transgenic mice bearing mammary carcinomaDosage: 100 mg/kg/day Administration: S.c. with osmotic mini-pumps for 14 days Result: Halted the tumors aggressive growth. Resulted in rapid tumor regression within 3 days of initiation of drug treatment. Form:Solid IC50& Target:IC50: 21 nM (GGTase I) |
| Smiles | CC(C)C[C@@H](C(O)=O)NC(C1=CC=C(NCC2=CN=CN2)C=C1C3=CC=CC=C3C)=O.[H]Cl |
|---|---|
| Molecular Weight | 456.97 |
| Solubility | DMSO : 250 mg/mL (547.08 mM; Need ultrasonic) H2O : 4.76 mg/mL (10.42 mM; ultrasonic and warming and heat to 60°C) |
|---|